14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
With costs coming down, a pre-existing supply chain, and other sites being developed nearby, Poland ...
Read More >
On April 22, 2020 Governor Tom Wolf announced that all businesses in the construction industry will ...
Read More >
On November 21, 2019, the EB-5 "Immigrant Investor Program Modernization" became effective. This is ...
Read More >
Seyfarth Synopsis: Employers face growing numbers of OSHA whistleblower complaints from aggrieved em...
Read More >
The Internal Revenue Service (IRS) issued Notice 2019-45, expanding the list of preventive care bene...
Read More >
In a decision of interest to private equity investors, the Delaware Court of Chancery (the “Court”...
Read More >